EW vs ITRM · P/E 47, rev $1.39B vs rev $390.0K
Edwards Lifesciences Corp (EW) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the EW and ITRM stock pages for the full models.
Not investment advice.